EWU vs XLV
iShares MSCI United Kingdom ETF vs Health Care Select Sector SPDR Fund
- • XLV has the lower expense ratio at 0.08% vs 0.50% for EWU.
- • EWU pays a higher dividend yield (3.14%).
Side-by-side metrics
| Metric | EWU | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.50% | 0.08% |
Dividend yield Trailing 12-month yield. | 3.14% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $3.73B | $49.10B |
YTD return | 11.45% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.66 | 0.41 |
P/E ratio | 16.65 | 30.63 |
Last price | $47.78 | $187.94 |
Inception | — | — |
Issuer | iShares | State Street |
EWU top holdings
| SHEL.L | Shell PLC | 9.88% |
| HSBA.L | HSBC Holdings PLC | 9.30% |
| AZN.L | AstraZeneca PLC | 8.93% |
| ULVR.L | Unilever PLC | 4.44% |
| RR.L | Rolls-Royce Holdings PLC | 4.37% |
| BP.L | BP PLC | 4.17% |
| BATS.L | British American Tobacco PLC | 3.89% |
| GSK.L | GSK PLC | 3.17% |
| RIO.L | Rio Tinto PLC Ordinary Shares | 2.75% |
| NG.L | National Grid PLC | 2.64% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About EWU
EWU (iShares MSCI United Kingdom ETF) is UK large and mid-cap equities. Managed by iShares, the fund carries $3.7B in assets under management, an expense ratio of 0.50%, a dividend yield of 3.14%. Its largest holding is Shell PLC (SHEL.L), which represents 9.9% of the portfolio. Real Estate is the fund's largest sector exposure at 0.7%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.